SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-17-000029
Filing Date
2017-02-28
Accepted
2017-02-28 17:18:09
Documents
20
Period of Report
2017-02-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ljpc-5018xk.htm 8-K 22104
2 EXHIBIT 99.1 pressreleaseexhibit.htm EX-99.1 20902
3 EXHIBIT 99.2 presentation.htm EX-99.2 15224
4 ljpcpressrelease_image1a06.jpg GRAPHIC 21134
5 presentation001.jpg GRAPHIC 47606
6 presentation002.jpg GRAPHIC 212981
7 presentation003.jpg GRAPHIC 74670
8 presentation004.jpg GRAPHIC 47766
9 presentation005.jpg GRAPHIC 131402
10 presentation006.jpg GRAPHIC 93045
11 presentation007.jpg GRAPHIC 169977
12 presentation008.jpg GRAPHIC 89635
13 presentation009.jpg GRAPHIC 49438
14 presentation010.jpg GRAPHIC 132994
15 presentation011.jpg GRAPHIC 145889
16 presentation012.jpg GRAPHIC 125853
17 presentation013.jpg GRAPHIC 102092
18 presentation014.jpg GRAPHIC 84396
19 presentation015.jpg GRAPHIC 99789
20 presentation016.jpg GRAPHIC 47730
  Complete submission text file 0000920465-17-000029.txt   2344804
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 17649260
SIC: 2836 Biological Products, (No Diagnostic Substances)